30 Day Trial

Captiva Spine Gains FDA Clearance for TirboLOX-L Cage

Share:

Captiva Spine received FDA 510(k) clearance to market TirboLOX-L, a titanium lumbar cage featuring a dual-layer lattice structure with a micro-rough surface, dual porosity and open architecture.

TirboLOX-L’s structure is designed to reduce radiographic presence for clear imaging, and its high coefficient of friction supports immediate bidirectional fixation, according to the company.

The device incorporates Captiva’s Pivotec® Pivoting TLIF cage, which is designed to addresschallenges of controlling cage insertion and angle manipulation during minimally invasive procedures.  

Source: Captiva Spine; Image courtesy of Captiva Spine